VC
ELV icon

Vestor Capital’s Elevance Health ELV Stock Holding History

Vestor Capital’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$482K Buy
1,646
+290
+21% +$95.3K 0.03% 105
2025
Q4 		$577K Sell
1,356
-990
-42% -$335K 0.04% 88
2025
Q3 		$758K Sell
2,346
-718
-23% -$223K 0.05% 98
2025
Q2 		$1.89M Buy
3,064
+718
+31% +$289K 0.14% 79
2025
Q1 		$1.02M Sell
2,346
-4
-0.2% -$1.61K 0.08% 87
2024
Q4 		$867K Buy
2,350
+4
+0.2% +$1.67K 0.07% 104
2024
Q3 		$1.22M Buy
2,346
+650
+38% +$347K 0.1% 72
2024
Q2 		$919K Buy
1,696
+540
+47% +$285K 0.07% 79
2024
Q1 		$599K Sell
1,156
-6
-0.5% -$2.98K 0.05% 101
2023
Q4 		$548K Hold
1,162
– – 0.05% 96
2023
Q3 		$506K Sell
1,162
-92
-7% -$41.7K 0.05% 98
2023
Q2 		$557K Sell
1,254
-22,972
-95% -$10.6M 0.06% 94
2023
Q1 		$11.1M Sell
24,226
-81
-0.3% -$38.5K 1.31% 23
2022
Q4 		$12.5M Sell
24,307
-249
-1% -$126K 1.5% 22
2022
Q3 		$11.2M Sell
24,556
-1,448
-6% -$693K 1.46% 22
2022
Q2 		$12.5M Buy
26,004
+24,779
+2,023% +$12.3M 1.52% 25
2022
Q1 		$602K Hold
1,225
– – 0.06% 90
2021
Q4 		$568K Hold
1,225
– – 0.05% 88
2021
Q3 		$457K Buy
+1,225
New +$466K 0.05% 97

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Vestor Capital's ELV Position: Q1 2026 in Review

Vestor Capital increased its Elevance Health (ELV) stake by 21% in Q1 2026, buying an estimated $95.3K and bringing the position to 1,646 shares worth $482K. The position accounts for 0.03% of the portfolio, ranked #105.

Vestor Capital first reported a position in ELV in Q3 2021 and has held it in 19 quarters since. The position peaked at $12.5M in Q2 2022. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Vestor Capital held 1,646 shares of Elevance Health worth $482K as of Q1 2026.
  • Vestor Capital bought 290 Elevance Health shares in Q1 2026, an estimated $95.3K.
  • Elevance Health made up 0.03% of Vestor Capital's portfolio in Q1 2026, its #105 holding.
  • Vestor Capital first reported a position in Elevance Health in Q3 2021 and has held it in 19 quarters since.
  • Vestor Capital's Elevance Health position peaked at $12.5M in Q2 2022.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Vestor Capital's 13F filing for Q1 2026, filed 21 May 2026.